BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 32758026)

  • 1. Initial Development of an Air-Jet Dry Powder Inhaler for Rapid Delivery of Pharmaceutical Aerosols to Infants.
    Howe C; Hindle M; Bonasera S; Rani V; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2021 Feb; 34(1):57-70. PubMed ID: 32758026
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Howe C; Momin MAM; Bass K; Aladwani G; Bonasera S; Hindle M; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2022 Aug; 35(4):196-211. PubMed ID: 35166601
    [No Abstract]   [Full Text] [Related]  

  • 3. Advancement of the Infant Air-Jet Dry Powder Inhaler (DPI): Evaluation of Different Positive-Pressure Air Sources and Flow Rates.
    Howe C; Momin MAM; Farkas DR; Bonasera S; Hindle M; Longest PW
    Pharm Res; 2021 Sep; 38(9):1615-1632. PubMed ID: 34462876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing Aerosolization Using Computational Fluid Dynamics in a Pediatric Air-Jet Dry Powder Inhaler.
    Bass K; Farkas D; Longest W
    AAPS PharmSciTech; 2019 Nov; 20(8):329. PubMed ID: 31676991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an Inline Dry Powder Inhaler for Oral or Trans-Nasal Aerosol Administration to Children.
    Farkas D; Hindle M; Bonasera S; Bass K; Longest W
    J Aerosol Med Pulm Drug Deliv; 2020 Apr; 33(2):83-98. PubMed ID: 31464559
    [No Abstract]   [Full Text] [Related]  

  • 6. Advancement of a Positive-Pressure Dry Powder Inhaler for Children: Use of a Vertical Aerosolization Chamber and Three-Dimensional Rod Array Interface.
    Farkas D; Bonasera S; Bass K; Hindle M; Longest PW
    Pharm Res; 2020 Aug; 37(9):177. PubMed ID: 32862295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation.
    Howe C; Momin MAM; Aladwani G; Hindle M; Longest PW
    Pharm Res; 2022 Dec; 39(12):3317-3330. PubMed ID: 36253630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations.
    Howe C; Momin MAM; Aladwani G; Strickler S; Hindle M; Longest W
    Int J Pharm; 2023 Aug; 643():123199. PubMed ID: 37406945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Inline Dry Powder Inhaler That Requires Low Air Volume.
    Farkas D; Hindle M; Longest PW
    J Aerosol Med Pulm Drug Deliv; 2018 Aug; 31(4):255-265. PubMed ID: 29261454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a New Inhaler for High-Efficiency Dispersion of Spray-Dried Powders Using Computational Fluid Dynamics (CFD) Modeling.
    Longest W; Farkas D
    AAPS J; 2019 Feb; 21(2):25. PubMed ID: 30734133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Air-Jet Dry Powder Insufflator for High-Efficiency Aerosol Delivery to Rats.
    Pangeni R; Hassan AAM; Farkas D; Sudarjat H; Longest W; Hindle M; Xu Q
    Mol Pharm; 2023 Apr; 20(4):2207-2216. PubMed ID: 36938947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model.
    Bass K; Momin MAM; Howe C; Aladwani G; Strickler S; Kolanjiyil AV; Hindle M; DiBlasi RM; Longest W
    AAPS PharmSciTech; 2022 Apr; 23(5):114. PubMed ID: 35441324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of an inline dry powder inhaler to deliver high dose pharmaceutical aerosols during low flow nasal cannula therapy.
    Farkas D; Hindle M; Longest PW
    Int J Pharm; 2018 Jul; 546(1-2):1-9. PubMed ID: 29733972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near Elimination of In Vitro Predicted Extrathoracic Aerosol Deposition in Children Using a Spray-Dried Antibiotic Formulation and Pediatric Air-Jet DPI.
    Farkas D; Thomas ML; Hassan A; Bonasera S; Hindle M; Longest W
    Pharm Res; 2023 May; 40(5):1193-1207. PubMed ID: 35761163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations.
    Boc S; Momin MAM; Farkas DR; Longest W; Hindle M
    AAPS PharmSciTech; 2021 Apr; 22(4):135. PubMed ID: 33860378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient Nose-to-Lung (N2L) Aerosol Delivery with a Dry Powder Inhaler.
    Longest PW; Golshahi L; Behara SR; Tian G; Farkas DR; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):189-201. PubMed ID: 25192072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children.
    Bass K; Longest W
    AAPS PharmSciTech; 2020 May; 21(5):157. PubMed ID: 32451773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient Nose-to-Lung Aerosol Delivery with an Inline DPI Requiring Low Actuation Air Volume.
    Farkas D; Hindle M; Longest PW
    Pharm Res; 2018 Aug; 35(10):194. PubMed ID: 30132207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.
    Longest W; Farkas D; Bass K; Hindle M
    Pharm Res; 2019 May; 36(8):110. PubMed ID: 31139939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.
    Son YJ; Worth Longest P; Hindle M
    Int J Pharm; 2013 Feb; 443(1-2):137-45. PubMed ID: 23313343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.